Is Intellia Therapeutics, Inc. (NTLA) a Buy, Sell, or Hold?
Intellia Therapeutics, Inc.
NASDAQ:NTLA
$13.04 USD
-$0.26 (-1.95%)
- Volume
- 3.92M
- Average Volume
- 6.91M
- Market Capitalization
- $1.46B
- P/E Ratio
- -3.68
- Dividend Yield
- 0.00%
- Price Target
- $25.00
- Year High
- $28.25
- Year Low
- $7.95
- Day High
- —
- Day Low
- —
- Payout Ratio
- $0.00
- Current Ratio
- $6.10
CCURRENT INSTITUTIONAL OWNERSHIP PERCENTAGE
0.46%
Investors Holding
14
change: -306 | last: 320
Increased Positions
4
change: -189 | last: 193
Reduced Positions
7
change: -57 | last: 64
New Positions
2
change: -60 | last: 62
Sold Positions
295
change: 244 | last: 51
Total Calls
-
Total Puts
-
Put-Call Ratio
0.00
change: -37.4354 | last: 0.3744
Total Invested
9.18M
NTLA Enterprise Value History
Annual
| Date | Stock Price | Shares Outstanding | Market Cap | Cash & Equivalents | Total Debt | Enterprise Value |
|---|---|---|---|---|---|---|
| 2025-12-31 | $8.99 | 108.38M | $974.3M | $155.46M | $93.33M | $912.17M |
| 2024-12-31 | $11.66 | 98.85M | $1.15B | $189.18M | $210.2M | $1.17B |
| 2023-12-31 | $30.49 | 88.77M | $2.71B | $226.75M | $115.35M | $2.6B |
| 2022-12-31 | $34.89 | 76.97M | $2.69B | $523.51M | $130.7M | $2.29B |
| 2021-12-31 | $118.24 | 70.89M | $8.38B | $123.41M | $74.02M | $8.33B |
| 2020-12-31 | $54.40 | 55.99M | $3.05B | $160.02M | $39.3M | $2.92B |
| 2019-12-31 | $14.67 | 47.25M | $693.11M | $57.23M | $18.38M | $654.26M |
| 2018-12-31 | $13.65 | 43.07M | $587.89M | $58.86M | $- | $529.04M |
| 2017-12-31 | $19.22 | 36.01M | $692.04M | $340.68M | $- | $351.36M |
| 2016-12-31 | $13.11 | 34.62M | $453.8M | $273.06M | $- | $180.74M |
Quarterly
| Date | Stock Price | Shares Outstanding | Market Cap | Cash & Equivalents | Total Debt | Enterprise Value |
|---|---|---|---|---|---|---|
| 2026-03-31 | $12.82 | 118.49M | $1.52B | $134.7M | $80.49M | $1.46B |
| 2025-12-31 | $8.99 | 108.38M | $974.3M | $155.46M | $93.33M | $912.17M |
| 2025-09-30 | $17.27 | 110.19M | $1.9B | $193.39M | $97.97M | $1.81B |
| 2025-06-30 | $9.38 | 103.73M | $973.01M | $156.17M | $102.59M | $919.43M |
| 2025-03-31 | $7.11 | 103.5M | $735.88M | $126.88M | $119.25M | $728.26M |
| 2024-12-31 | $11.66 | 101.86M | $1.19B | $189.18M | $210.2M | $1.21B |
| 2024-09-30 | $20.55 | 101M | $2.08B | $120.5M | $101.62M | $2.06B |
| 2024-06-30 | $22.47 | 96.98M | $2.18B | $130.85M | $106.3M | $2.15B |
| 2024-03-31 | $27.22 | 95.5M | $2.6B | $171.98M | $110.86M | $2.54B |
| 2023-12-31 | $30.49 | 90.46M | $2.76B | $226.75M | $115.35M | $2.65B |
| 2023-09-30 | $31.62 | 88.64M | $2.8B | $168.03M | $118.34M | $2.75B |
| 2023-06-30 | $40.78 | 88.18M | $3.6B | $171.81M | $122.33M | $3.55B |